Teleflex Inc. (TBH)
XDUS 
Summary
TBH Chart
Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Stockholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / April 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE:TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TFX.
Teleflex to Present at the BofA Securities 2025 Health Care Conference
WAYNE, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX), will be presenting at the BofA Securities 2025 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Wednesday, May 14, 2025, at 1:40 p.m. (PT).
Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device
WAYNE, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of an expansion to the Indications for Use of the QuikClot Control+™ Hemostatic Device to include all grades of internal and external bleeding. The QuikClot Control+™ Device was previously indicated for temporary control of class III and class IV internal organ space bleeding, severely bleeding surgical wounds, mild and moderate bleeding in cardiac surgical procedures, and bone surfaces following sternotomy.
Teleflex Inc. Dividends
| TFX In 1 month Estimated | Quarterly | $0.34 Per Share |
| TFX 1 month ago Paid | Quarterly | $0.34 Per Share |
| TFX 5 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 8 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 11 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 29 Feb 2024 Paid | Quarterly | $0.34 Per Share |
Teleflex Inc. Earnings
| 30 Apr 2025 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 20 Feb 2025 Date | | 3.88 Cons. EPS | 3.89 EPS |
| 31 Oct 2024 Date | | 3.39 Cons. EPS | 3.49 EPS |
| 1 Aug 2024 Date | | 3.33 Cons. EPS | 3.42 EPS |
| 3 May 2024 Date | | 3.07 Cons. EPS | 3.21 EPS |
| TFX In 1 month Estimated | Quarterly | $0.34 Per Share |
| TFX 1 month ago Paid | Quarterly | $0.34 Per Share |
| TFX 5 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 8 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 11 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 29 Feb 2024 Paid | Quarterly | $0.34 Per Share |
| 30 Apr 2025 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 20 Feb 2025 Date | | 3.88 Cons. EPS | 3.89 EPS |
| 31 Oct 2024 Date | | 3.39 Cons. EPS | 3.49 EPS |
| 1 Aug 2024 Date | | 3.33 Cons. EPS | 3.42 EPS |
| 3 May 2024 Date | | 3.07 Cons. EPS | 3.21 EPS |
Teleflex Inc. (TBH) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Teleflex Inc. ever had a stock split?
Teleflex Inc. Profile
| Medical Instruments & Supplies Industry | Healthcare Sector | Mr. Liam J. Kelly CEO | XDUS Exchange | US8793691069 ISIN |
| United States Country | 14,500 Employees | 7 Mar 2025 Last Dividend | 17 Jun 1997 Last Split | 18 Feb 1988 IPO Date |
Overview
Teleflex Incorporated is a global leader in the development, manufacturing, and supply of single-use medical devices for diagnostic and therapeutic procedures in critical care and surgical applications. The company has a rich history dating back to 1943 and is headquartered in Wayne, Pennsylvania. Serving hospitals, healthcare providers, medical device manufacturers, and the home care market, Teleflex aims to improve the health and quality of life of patients worldwide with its innovative medical technologies.
Products and Services
- Vascular Access Products: Includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems, designed for the administration of intravenous therapies, blood pressure measurement, and the withdrawal of blood samples through a single puncture site.
- Interventional Products: Comprises a range of coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platforms. These are utilized by interventional cardiologists, radiologists, and vascular surgeons and include Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
- Anesthesia Products: Offers airway and pain management products that support hospital, emergency medicine, and military channels, ensuring the patient's comfort and safety during medical procedures.
- Surgical Products: Provides metal and polymer ligation clips and fascial closure surgical systems for use in laparoscopic surgeries, percutaneous surgical systems, and a range of other surgical instruments, enabling surgeons to perform with precision and efficiency.
- Interventional Urology Products: Features the UroLift System, an innovative technology for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia, offering a minimally invasive alternative to traditional procedures.
- Respiratory Products: Includes oxygen and aerosol therapies, spirometry, and ventilation management products for various care settings, aiding in the respiratory care of patients across a broad spectrum of care environments.
- Urology Products: Offers a comprehensive range of catheters, urine collectors, catheterization accessories, and products for operative endourology, supporting the needs of patients with urologic conditions.
- Bladder Management Services: Provides a suite of services and products for effective bladder management, enhancing the quality of life for patients dealing with bladder-related health issues.
Contact Information
